{{Rsnum
|rsid=35939430
|Chromosome=11
|Orientation=minus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=HBB
|position=5225654
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=HBB
}}{{omim
|id=141900
|rsnum=35939430
|variant=0058
}}{{ClinVar
|rsid=35939430
|Reversed=1
|FwdREF=G
|FwdALT=C
|REF=C
|ALT=G
|RSPOS=5246884
|CHROM=11
|dbSNPBuildID=126
|SSR=0
|SAO=1
|VP=0x050368000000000102110100
|GENEINFO=HBB:3043
|GENE_NAME=HBB
|GENE_ID=3043
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000011.9:g.5246884C>G
|CLNORIGIN=1
|CLNSIG=255
|Tags=RV;PM;PMC;S3D;SLO;GNO;OTHERKG;LSD;OM
|CLNACC=RCV000016309.1
|CLNDBN=HEMOGLOBIN CRETE
|CLNSRC=HBVAR; OMIM Allelic Variant
|CLNSRCID=530; 141900.0058
|Disease=HEMOGLOBIN CRETE
}}{{PMID Auto
|PMID=36184
|Title=Hemoglobin Crete (beta 129 ala leads to pro): a new high-affinity variant interacting with beta o -and delta beta o -thalassemia.
}}

{{PMID Auto
|PMID=15658190
|Title=Molecular characterization and diagnosis of Hb Crete [beta129(H7)Ala-->Pro].
}}